In vitro activity of new rifamycins aganst rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria
- 1 September 1987
- journal article
- research article
- Published by Elsevier BV in Tubercle
- Vol. 68 (3), 177-182
- https://doi.org/10.1016/0041-3879(87)90053-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- LM 427,a new spiropiperidylrifamycin: In vitro and in vivo studies.The Journal of Antibiotics, 1983
- INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-AVIUM COMPLEX AND MYCOBACTERIUM-TUBERCULOSIS STRAINS TO A SPIRO-PIPERIDYL RIFAMYCINPublished by Elsevier BV ,1982
- Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative.The Journal of Antibiotics, 1981
- Biological activity of a new class of rifamycins Spiro-piperidyl-rifamycins.The Journal of Antibiotics, 1980
- Physiological disposition of a series of rifamycins in rat: A comparative study.The Journal of Antibiotics, 1978
- Studies of binding C3-substitute rifamycins to human and bovine serum albumin.The Journal of Antibiotics, 1977
- Co-operative controlled trial of a standard regimen of streptomycin,pas and isoniazid and three alternative regimens of chemotherapy in Britain A report from the British Medical Research CouncilTubercle, 1973
- A Selective Oleic Acid Albumin Agar Medium For Tubercle BacilliJournal of Medical Microbiology, 1972